{
    "organizations": [],
    "uuid": "6a93ea446a75cfc577971cea2a54d46aa4990e56",
    "author": "",
    "url": "https://www.reuters.com/article/brief-bd-statement-on-fda-warning-letter/brief-bd-statement-on-fda-warning-letter-for-preanalytical-systems-business-unit-idUSFWN1P70OM",
    "ord_in_thread": 0,
    "title": "BRIEF-BD Statement On FDA Warning Letter For Preanalytical Systems Business Unit",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 12, 2018 / 2:36 PM / in 27 minutes BRIEF-BD Statement On FDA Warning Letter For Preanalytical Systems Business Unit Reuters Staff \nJan 12 (Reuters) - Becton Dickinson And Co: \n* BD STATEMENT ON FDA WARNING LETTER FOR PREANALYTICAL SYSTEMS BUSINESS UNIT \n* BECTON DICKINSON - AFTER FDA INSPECTION IN JULY, TOOK ACTION THAT CO BELIEVED FULLY ADDRESSED AGENCY‘S INSPECTIONAL OBSERVATIONS \n* BECTON DICKINSON - “CAREFULLY REVIEWING” FDA‘S FEEDBACK OUTLINED IN LETTER WITH HIGHEST SENSE OF URGENCY, TO PROVIDE FULL RESPONSE ON OR BEFORE FEB 1 Source text for Eikon: Further company coverage:",
    "published": "2018-01-12T16:35:00.000+02:00",
    "crawled": "2018-01-12T17:04:16.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "minute",
        "statement",
        "fda",
        "warning",
        "letter",
        "preanalytical",
        "system",
        "business",
        "unit",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "becton",
        "dickinson",
        "co",
        "bd",
        "statement",
        "fda",
        "warning",
        "letter",
        "preanalytical",
        "system",
        "business",
        "unit",
        "becton",
        "dickinson",
        "fda",
        "inspection",
        "july",
        "took",
        "action",
        "co",
        "believed",
        "fully",
        "addressed",
        "agency",
        "inspectional",
        "observation",
        "becton",
        "dickinson",
        "carefully",
        "reviewing",
        "fda",
        "feedback",
        "outlined",
        "letter",
        "highest",
        "sense",
        "urgency",
        "provide",
        "full",
        "response",
        "feb",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}